Appendix A — Clinic rollout & network build
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
|---|---|---|---|---|---|
|
Clinics open |
3 |
6 |
9 |
9 |
9 |
|
Network maturity |
13% |
37% |
71% |
91% |
100% |
|
Consultations |
24,000 |
67,259 |
127,259 |
163,259 |
180,000 |
|
Surgeries |
2,667 |
7,473 |
14,140 |
18,140 |
20,000 |
|
Optical sales |
13,333 |
37,366 |
70,700 |
90,700 |
100,000 |
|
Revenue per open clinic (R m) |
54 |
76 |
95 |
122 |
135 |
Appendix B — Depreciation, interest & tax (R m)
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
|---|---|---|---|---|---|
|
Depreciation (by component) |
19 |
38 |
57 |
62 |
69 |
|
Gross PP&E |
138 |
276 |
414 |
449 |
494 |
|
Accumulated depreciation |
19 |
57 |
115 |
177 |
246 |
|
Interest expense |
5 |
13 |
18 |
17 |
12 |
|
Debt (closing) |
90 |
140 |
170 |
130 |
80 |
|
Taxation |
0 |
0 |
3 |
35 |
50 |
Appendix C — Revenue by service line (R m)
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
|---|---|---|---|---|---|
|
Surgical services |
78 |
218 |
412 |
529 |
583 |
|
Consultations & diagnostics |
36 |
100 |
189 |
242 |
267 |
|
Optical & contact lenses |
34 |
95 |
180 |
231 |
255 |
|
Corporate & screening |
10 |
27 |
52 |
66 |
73 |
|
Telemedicine & government |
5 |
14 |
26 |
33 |
36 |
|
Total revenue |
162 |
454 |
859 |
1,102 |
1,215 |
Appendix D — Key assumptions register
|
Assumption |
Value |
|---|---|
|
Clinics / rollout |
9 flagship; 3 / 3 / 3 over Years 1–3 |
|
Mature revenue per clinic |
~R135m; ramp ~40/72/100% by age |
|
Year-5 revenue / margin |
> R1.2bn / ~22% (target 20–25%) |
|
Depreciation |
Straight-line by component, 4–10 yr |
|
Cost of debt / tax |
11.5% / 27% with loss cap |
|
Working capital |
~9% of revenue (medical-aid receivables) |
|
Exit |
8.5x EV/EBITDA (8–12.5x tested) |
|
Combined-stress IRR |
~53% (ramp –20%, margin –20%, 8x exit) |
Appendix E — Glossary
|
Term |
Definition |
|---|---|
|
Hub-and-spoke |
A network model with a flagship hub per province and later satellite clinics. |
|
Rollout J-curve |
Negative early returns during the build/ramp, before strong later profitability. |
|
Network maturity |
How full and productive the open clinics are, versus their mature run-rate. |
|
Cataract surgical rate (CSR) |
Cataract surgeries per million population per year — a WHO access measure. |
|
Tele-ophthalmology |
Remote specialist consultation and screening, extending scarce specialists. |
|
CFADS / DSCR |
Cash flow available for debt service; and CFADS divided by scheduled debt service. |
|
MOIC |
Multiple of invested capital — total distributions divided by equity invested. |
|
NHI |
National Health Insurance — SA’s proposed universal health-financing reform. |
Appendix F — Important notice
This document is strictly private and confidential. It has been prepared for the exclusive use of prospective financiers and does not constitute an offer of securities, investment advice or medical advice. All projections are estimates built to be consistent with the sponsor’s stated targets and are subject to material risk, of which specialist-recruitment, clinic-ramp, early-year liquidity and regulatory (medical-aid / NHI) risk are the most significant.